Medication info
DucaM Tablet 60/2.5 mg

DucaM Tablet 60/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceuticals Co., Ltd.
Appearance
Yellow, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300127 · Approved 2023.01.06 · Insurance code 622804940

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted with fimasartan before administering this medicine. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Mothers Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication helps to lower blood pressure more effectively and reduce the risk of complications from hypertension in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Pimasartan Potassium. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted with fimasartan before administering this medicine. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. It must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergic reactions to this medication, certain liver diseases, patients on kidney dialysis, patients with biliary obstruction, and some heart diseases. Patients who are volume-depleted or salt-depleted, those with impaired kidney function, and elderly patients need caution while using this medication, and their condition should be closely monitored. Side effects such as dizziness, headache, facial swelling, urination problems, insomnia, and flushing may occur during use, so any abnormal symptoms should be consulted with healthcare professionals. Patients with low blood pressure or electrolyte imbalance should correct these conditions before taking this medication and should periodically monitor blood pressure and serum electrolyte levels during treatment. This drug may enhance blood pressure-lowering effects when used with other antihypertensive drugs or diuretics, so it should be taken under the guidance of healthcare professionals. Pregnant or breastfeeding women are advised to avoid this medication, and particularly in breastfeeding cases, it is recommended to stop breastfeeding or discontinue the medication. Safety in pediatric patients has not been established, so it is preferable not to use in patients under 18 years of age. Overdosage can lead to severe hypotension or cardiac abnormalities. Therefore, it is crucial to adhere to the prescribed dosage and seek medical attention immediately in case of overdose. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • dysuria
  • insomnia
  • flushing
  • syncope
  • sedation
Show 151 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • asthenia
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal rigidity
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuritis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon cancer
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute kidney failure
  • chronic kidney failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • interstitial pneumonia
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • worsening low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • edema
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • paresthesia
  • numbness
  • tremor
  • muscle rigidity
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • anorexia
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disease
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • frequent urination
  • urinary incontinence
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure variability
  • fatty liver
  • postoperative pain
  • allergy
  • chills
  • nasal polyp
  • pneumonia
  • hemoptysis
  • asthma
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • sounds from the ear
  • visual disturbances
  • increased urination frequency
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • blood pressure drop
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precardiac pain
  • loose stools
  • rash
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • reduced glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in an opaque container that does not allow light to enter. Additionally, it is advisable to keep it at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Yellow, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.